Cite
HARVARD Citation
Platt, H. et al. (2023). Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in healthy adults: phase 1/2, randomised, double-blind, active comparator-controlled, multicentre, US-based trial. Lancet infectious diseases. 23 (2), pp. 233-246. [Online].